An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma
Kapoor, Prashant, Nathwani, Nitya, Jelinek, Tomas, Pour, Ludek, Perrot, Aurore, Dimopoulos, Meletios‐Athanasios, Huang, Shang‐Yi, Spicka, Ivan, Chhabra, Saurabh, Lichtman, Eben, Mateos, Maria‐Victoria, Kanagavel, Dheepak, Zhao, Liang, Guillemin‐Paveau, Helene, Macé, Sandrine, Velde, Helgi, Richardson, Paul G.
Published in European journal of haematology (01.11.2024)
Published in European journal of haematology (01.11.2024)
Get full text
Journal Article
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study
Sunami, Kazutaka, Suzuki, Kenshi, Ri, Masaki, Matsumoto, Morio, Shimazaki, Chihiro, Asaoku, Hideki, Shibayama, Hirohiko, Ishizawa, Kenichi, Takamatsu, Hiroyuki, Ikeda, Takashi, Maruyama, Dai, Kaneko, Hitomi, Uchiyama, Michihiro, Kiguchi, Toru, Iyama, Satoshi, Murakami, Hirokazu, Takahashi, Keishiro, Tada, Keisuke, Macé, Sandrine, Guillemin‐Paveau, Hélène, Iida, Shinsuke
Published in Cancer science (01.12.2020)
Published in Cancer science (01.12.2020)
Get full text
Journal Article
779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
Gutierrez, Martin, Garralda, Elena, Calvo, Emiliano, Dongen, Marloes van, Eskens, Ferry, Finlay, Morgan, Menas, Fatima, Zhu, Chen, Wu, Meijing, Guillemin-Paveau, Helene, Abbadessa, Giovanni, Perez, Raymond, Yildirim, Ozlem, Naing, Aung
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors
Luke, Jason, Olszanski, Anthony J, Rosen, Lee, Tarhini, Ahmad A, Baakili, Adyb, Wagenaar, Timothy, Zhu, Chen, Guillemin-Paveau, Helene, Wu, Meijing, Perez, Raymond, Abbadessa, Giovanni, Fountzilas, Christos
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Safety, pharmacokinetic and pharmacodynamic results from dose escalation of SAR439459, a TGFβ inhibitor, as monotherapy or in combination with cemiplimab in a phase 1/1b study
Williamson, Stephen K., Hodi, F. Stephen, Johnson, Melissa Lynne, Barve, Minal A., Juric, Dejan, Baranda, Joaquina Celebre, Schneider, Reva Elaine, Bauer, Todd Michael, Lin, Tun Tun, Wang, Rui, Amrate, Amele, Guillemin-Paveau, Helene, Sullivan, Ryan J.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article